NEW
THE RIGHT RESULTS, THE FIRST TIME Avoid ineffi ciencies with a 93% fi rst-pass yield1
When important patient care decisions are on the line, you need results you can count on—the first time. The DxH 900 hematology analyzer first-pass yield enables predictable costs and maximizes staff time by:
› Delivering accurate results with fewer reruns using near native-state cellular characterization and DataFusion technology—a unique combination of multiple testing methods for precise, high-resolution analysis in a single run
› Ensuring predictable costs through industry-leading 93% first-pass throughput1
for accurate flagging and a reduced number of slide reviews
›Maximizing staff time by reducing the time and supply costs related to managing systems with higher repeat rates, and simplifying workflow through a lean reagent portfolio
Learn more about how laboratories can achieve Lean practices and minimize repeat rates with the DxH 900 analyzer.
Visit
www.beckmancoulter.com/dxh900-MLO
1. Percentage of samples with numerical results that do not require additional intervention or handling, such as manual smear review, spun hematocrit, dilution, or other repeat/refl ex testing. DxH series side-by-side results documentation.
© 2019 Beckman Coulter, Inc. All rights reserved. Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries.
For more information, visit
www.beckmancoulter.com/contact AD-180261
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48
